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During the course ofa cell-mediated immune response, effector mechanisms are
induced that lead to the selective destruction of host cells . This was first brought
to our attention during ultrastructural analysis of tuberculoid leprosy lesions. Hence,
in the paucibacillary form of leprosy, parasitized and foamy macrophages and
epithelioid cells were being destroyed in association with highly polarized lympho-
cytes of an unknown phenotype (1, 2) . More recently, this has been observed in the
lesionsoflepromatous leprosy afterthegeneration of an antigen driven purified protein
derivative [PPD] cell mediated response . In this instance, infected macrophages liberate
large numbers of Micobacterium leprae and their products into the extracellular envi-
ronment (3). Parasitized macrophages are destroyed in a milieu containing many
newly immigrated mononuclear cells, including CD4+ and CD8+ T cells, mono-
cytes, and T6+ Langerhans' cells (4) . This scenario has also been observed after the
introduction of the recombinant lymphokines IFN-.y (manuscript in preparation)
and IL-2 (5) into the lesions of lepromatous and borderline lepromatous leprosy
patients . Under these conditionsM . leprae is subsequently reingested and disman-
tled, leading to a striking local reduction in bacilli .
To examine thenature ofthe cytotoxic cell(s) involved and theirrecognitionmech-
anism(s), we havenowperformed in vitro analyses . We have usedhumanmonocytes
as targets and PBMC or enriched lymphocyte subsets as the source of killer cells .
Both targets and effector cellshave been exposedto antigens contained in PPD that
crossreact with many species of Mycobacteria . In addition, we examine the role of
IL-2 after its injection into lepromatouspatients and added in culture on the gener-
ation of specific and nonspecific effector cells .
Materials and Methods
Tuberculin Skin-test lbsitive Donors.
￿
Donors were selected from healthy laboratorypersonnel .
Patient Pbpulation .
￿
Eight patients with lepromatous leprosy were seen at the All Africa
Leprosy Rehabilitation and Training hospital and theArmauer Hansen Research Institute,
Addis Ababa, Ethiopia. Each patient was injected intradermally with three doses of 10 Rg
human rIL-2 (Cetus Corp ., Emeryville, CA) at 48-h intervals (5) . Immediately before and
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8-14 d after the initiation of rIL-2 injections, 50 ml of peripheral blood was obtained from
each patient. Antigen-dependent cytolytic activity (see below) was determined after 7 d stim-
ulation in vitro with Bacillus Calmette-Guerin (BCG; Statens Serumstitut, Copenhagen,
Denmark).
Effector Cells.
￿
Human PBMC from PPD-sensitized donors were isolated on Ficoll-Hypaque
(Pharmacia Fine Chemicals, Piscataway, NJ). T lymphocytes were enriched by adherence
to neuraminidase (Fibrio cholera neuraminidase, Calbiochem-Behring Corp., LaJolla, CA)-
treated SRBC and separated from nonadherent fractions over Ficoll-Hypaque. The T lym-
phocytes (2 x 106/ml) were cultured 0-8 d in 60-mm tissue culture dishes (Falcon Labware,
Oxnard, CA) with 10 pg PPD/ml RPMI 1640 (Gibco Laboratories, Grand Island, NY) sup-
plemented with 10% human AB' serum, 1001Ag penicillin/ml, 100 wg streptomycin/ml, and
2 mM glutamine (RIO). SRBC nonadherent fractions (0.8-1.2 x 106 cells) were added to
facilitate antigen presentation. In some experiments, rIL-2 (40 U/ml) was added on days
0 and 3 of culture, (Collaborative Research, Lexington, MA) and in others, 1,000 U/ml was
added at day 0 only (Cetus Corp., Emeryville, CA).
PBMC (1-2 x 106/ml) from lepromatous leprosy patients were stimulated in 24-well tissue
culture dishes (Linbro; Flow Laboratories, Inc., McLean, VA) with BCG (2.5 lAg/ml) ormedium
alone. After 7 d ofculture, effector cells were harvested, washed in cold RPMI, and adjusted
to a final concentration of 1-5 x 106/ml RIO.
Panning
￿
Effector cells were enriched for CD4' and CD8' cells as described (6, 7).
Briefly, effector cells were incubated 1 h on ice with OKT4 (CD4) (CRL 8002; American
Type Culture Collection, Rockville, MD) or OKT8 (CD8) (CRL 8014; American Type Cul-
ture Collection) mAb containing supernatants, washed, and panned on 100-mm petri dishes
(1005; Falcon Labware) coated with 60 kg ofthe IgG fraction ofgoat anti-mouse Fc (0211-0121;
Cappel Laboratories, Cochranville, PA). Cells bearing the Fc receptor were depleted from
effector populations by incubation for 30 min in 100-mm Petri dishes coated with human
Ig (10 mg/ml) (0001-0910; Cappel Laboratories) (7).
Preparation ofMonocyte-enriched Targets.
￿
Autologousmonocyte-enriched targets (SRBC nonad-
herent PBMC) were isolated from donors either 1 d before the cytotoxicity assay, or at the
time the PBMC were obtained for in vitro stimulation with antigen, cultured (106/ml RIO)
in Teflon beakers (Savillex Corporation, Minnetonka, MN) and incubated, before assay, on
ice for 1 h to increase cell yields. In some experiments, monocyte targets were recovered from
the Teflon beakers and added (104/well) to 96-well round-bottomed tissue culture dishes for
overnight adherence in the presence ofantigen. In other experiments, the targets were pulsed
overnight in the Teflon beakers with antigen, labeled with 5'Cr, and then added to 96-well
round-bottomed tissue culture dishes (104/well) with antigen immediately before initiation
of the assay.
Antigens.
￿
The antigens used were PPD of tuberculin (Statens Serumstitut, Copenhagen,
Denmark) (401Ag/ml overnight and 1 kg/well during the assay, or 1 hg/well overnight); M. lep-
rae soluble filtrate (40 lag/ml overnight and 4 hg/ml during the assay, or 4 ug/well overnight);
and tetanus toxoid (TT 1 :300 finaldilution overnight or 1 :500 finaldilution during the assay
of a 770 Lf/ml solution).
Determination ofPercent Specific 51Cr Release.
￿
"Cr (New England Nuclear, Boston, MA) re-
lease was determined after 4 or 15 h of incubation.
4-h Assay (7).
￿
Briefly, 50 I.1 (104 cells) of 5'Cr-labeled monocytes were incubated (37 °C,
5% CO2) with increasing concentrations of effector cells (in 100 JAI volumes) in triplicate
round-bottomed microwells (Costar, Cambridge, MA). At the end of incubation, culture
supernatant was measured for 5'Cr release and compared with spontaneous release (mono-
cytes cultured with medium alone, 15-25%) and total release (monocytescultured in medium
containing 1% SDS, vol/vol in PBS). Percent specific 5'Cr release was determined by: 100 x
[(mean cpm experimental) - (mean cpm spontaneous release)]/[(mean cpm total release) -
(mean cpm spontaneous release)].
15-h Assay.
￿
Specific 5'Cr release after 15 h incubation was determined in a modified assay.
Briefly, PBMC isolated at the time the PBMC were obtained for in vitro stimulation with
antigen were cultured (5 x 104/well) in 96-well round-bottomed dishes, and the adherent
cells served as monocyte targets. Alternatively, SRBC nonadherent monocyte targets, alsoisolated at the initiation of antigen stimulation in vitro, were cultured in Teflon beakers, har-
vested 1 d before the cytotoxic assay, adjusted to 2 x 105/ml RIO, added to 96-well round-
bottomed tissue culture dishes (50141, 104/well), and incubated 2 h (37'C, 5% C02) to allow
monocyte target adherence. After incubation, the nonadherent cells were removed and 50
Al warm RIO was added. The monocyte targets were charged with antigen overnight. The
monocytes were then washed with warm RPMI (5% A' human serum) and labeled with
"Cr (1.25 FtCi/well) for 6-7 h, washed, and incubated 15 h with increasing numbers of
effector cells. After supernatant harvest, 100 pl of 1% Triton X (vol/vol, in PBS) was added
to each well, incubated 3 h (37°C), and collected. Percent specific "Cr release was deter-
mined by: 100 x (test cpm)/(test cpm + cpm from the same Triton X-treated well) - per-
cent spontaneous release. Percent spontaneous release was usually 20-30%.
NK and Lymphokine-activated Killer (LAK) Cell Assay.
￿
NK (K562) (8) and LAK (Daudi)
(9) targets were obtained from C-C Liu (The Rockefeller University, New York, NY) and
cultured in RPMI 1640 supplemented with 10% heat-inactivated (56°C, 30 min) FCS (Hy-
clone Laboratories, Logan, UT), 100 Fcg penicillin/ml, 100,ug streptomycin/ml, and 2 mM
glutamine. The targets were harvested, labeled 1-2 h with 5 'Cr (100 JCi/10' targets), washed,
added to 96-well round-bottomed tissue culture dishes (104/well), and incubated 4 h (37°C,
517o C02) with increasing numbers of effector cells. Percent specific "Cr release was deter-
mined as above.
Immuno luorescence.
￿
The cellular composition ofthe PPD-stimulated effectors obtained from
the tuberculin-sensitive donors and theirenriched subpopulations was determined by staining
in suspension (2 x 105 cells/round-bottomed microwell; Costar) with Leu-3a/Leu-2a
"Simultest" (Becton Dickinson & Co., Mountain View, CA) and immunofluorescence was
analyzed with FACScan flow cytometer (Becton Dickinson & Co.) .
Inhibition of Cytolytic Activity with mAb Directed against MHC Determinants.
￿
The enriched
effectors and monocyte targets (E/T ratio 20:1) were incubated during the cytotoxicity assay
with increasing concentrations (percent, vol/vol) ofhybridoma supernatants containing mAbs
9.3C9 (anti-class II MHC products), L243 (anti-HLA-DR), or W6/32 (anti-class I, A, B,
C) (HB 180, HB 55, and HB 95, respectively; American Type Culture Collection).
Results
PPD-stimulatedPBMC Yield Cytotoxic CellsforAntigenpulsedMonocytes.
￿
PBMC from
previously sensitized normal donors were stimulated in vitro with PPD. After 8 d
of culture with PPD, the PBMC killed monocytes that had been pulsed with the
sensitizing antigen, but not the monocytes pulsed with nonrelated antigen (tetanus
toxoid) or medium alone (Fig. 1). Only at very high E/T ratios (50:1) was some
antigen-independent killing of targets observed. PBMC that had not been stimu-
lated with PPD were not cytotoxic. PPD-stimulated PBMC also demonstrated cyto-
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FIGURE 1.
￿
PPD-stimulated PBMC contain antigen-dependent
cytotoxic cells for autologous monocyte targets. Monocyte
targets were pulsed overnight with PPD (", A), TT (G, 0),
or medium alone (O, A) and then exposed to PBMC stimu-
lated 8 d with either PPD (circles) or medium alone (triangles)
at the indicated ratios. After 4 h incubation, percent specific
"Cr release was determined.912
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lyticactivity against monocytes pulsed withthe crossreactive antigenM. leprae (Table
I). Stimulation ofthe PBMC with both PPD and rIL-2 in vitro did not enhance
theM. leprae-specific cytotoxicactivity but did induce antigen-independent nonspecific
cytolytic activity against monocytes. This data suggestedthat specific and nonspecific
cytolyticsubpopulation(s) were generatedduring the in vitro stimulationwith PPD.
Antigen-speck CTL Are Largely of the CD4' Subset.
￿
To characterize the cell popu-
lation thatmediated antigen-specificmonocyte killing, PPD-stimulated PBMC were
enriched for CD4' or CD8+ cells. The bulk PBMC killed antigen-pulsed mono-
FIGURE 2.
￿
In vitro stimulation
ofPBMC with PPD generates
antigen-dependent CD4' CTL.
Fig. 2 represents data from
two experiments, experiment 1
C
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TABLE I
PPD-stimulated PBMC Contain Cells Cytotoxic for
Monocyte Targets Pulsed with M. leprae
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Effector (PBMC)
stimulation PPD
Percent specific release* from
monocytes pulsed with:
M. leprae T. toxoid
PPD 17 18 0
PPD + IL-2 29 28 8
IL-2 2 11 0
None 0 10 0cytes only if the PBMC had been cultured for 7 d with antigen (compare Fig. 2
A and B). If CD4' cells were removed by panning with OKT4 mAb, the CD4-
PBMC retained only low levels ofkilling capacity (Fig. 2 C). In contrast, depletion
of the CD8' subset with OKT8 mAb did not reduce cytolytic activity (Fig. 2 E).
The data in Fig. 2 Cand E suggested that CD8' suppressor/cytotoxic T cells were
not the mediators of monocyte killing in this system. Positively selected CD4' T
cells showed active killing (Fig. 2 D). Taken together, these observations suggested
that the CD4+ population was the antigen-specific cytolytic population. In addi-
tion, these studies suggested that the PPD-stimulated PBMC also contained CD4-,
HANCOCK ET AL.
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ANTIBODY [% SUPERNATANT]
FIGURE 3.
￿
CD4' CTL are classII MHC restricted. Fig. 3 represents data from threeseparate
experiments. The monocyte targets were incubated during the assaywith increasing concentra-
tions (percent; vol/vol) ofhybridomasupernatants from three different clones secreting mAb to
HLA-DR (A-C) or to HLA-A, B, C (D andE). Theeffectors were PPD-stimulated PBMC popu-
lationsat an E/Tratioof20:1 .After 15 h incubation, percent cytolytic activity wasdetermined.
(A)9.3C9 (anti-class II antibody)hybridomasupernatant inhibited thecytolytic activity ofPPD-
stimulated CD8- PBMC (", O) directed against monocyte targetspulsed with PPD(filledcircles),
buthadno effect on monocyte targetsfedmedium alone(opencircles). 9.3C9 hybridomasuperna-
tant also inhibited the cytolytic activity of CD4' T cells (+, 0) against monocytes fed PPD
(filled symbols), but notthosemonocytesfedwith medium alone(opensymbols). (B) L243 hybridoma
supernatant containing monomorphic anti-DR mAb inhibited the cytolytic activity of CD4'
T cells (*, 0) in two separate experiments against monocyte targets pulsed with PPD (filled
symbols), butnot against monocyte targets fed medium alone (opensymbols). (C L243 hybridoma
supernatant didnotaffect the cytotoxicity of CD4- PBMC (/, EI)directed against monocytes
fed with PPD (filledsymbols) or medium alone (open symbols). (D) In two separate experiments,
hybridoma supernatant containing mAb directed against class I MHC determinants (W6/32;
A, B, Cdid not blockthe cytolytic activity ofCD4' T cells (*, 0) directed against monocytes
pulsed with PPD (filledsymbols) and had no effect on monocyte targets fed medium alone(open
symbols). (E) W6/32 hybridoma supernatant didnotaffect theantigen-independent cytolytic ac-
tivity of PPD-stimulated CD4- PBMC directed against either monocytes fed with PPD (filled
symbols) or medium alone (open symbols). Error bars represent 1 SEM.914
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CD8- cells that mediated nonspecific killing. NK or LAK cells could be the medi-
ators of this effect.
PPD-stimulated CTL Are MHC Class II Restricted.
￿
CD4+ CTL are known to be
MHC class II restricted (10). To verify this in oursystem, killing assays were carried
out in the presence of mAb specific for class I (W6/32) or class II antigens (9.3C9
and L243; Fig. 3). Only the latter mAb blocked. CD4+ T cell cytotoxicity was in-
hibited by the presence ofanti-class II (Fig. 3, A and B), but not by the anti-class
I mAb (Fig. 3 D). The low level of antigen-independent cytotoxicity in our system
was not affected by either anti-class I or anti-class II mAb (Fig. 3, A, C, and E).
These observations indicated that antigen-specific CD4* T cells were class II re-
stricted, while antigen-independent CD4- , CD8- cells were not MHC restricted.
Antigen-independent Cytotoxic Activity Generated by PPD Stimulation ofPBMC.
￿
Simul-
taneously with the generation of the CD4+ CTL (Fig. 4 C), PPD stimulation of
PBMC generated aminorpopulation ofCytotoxic cells. This activity was moreeasily
demonstrated by enrichment ofthe CD4- effector population (Fig. 4 D). The CD4-
cells, 8% ofthe PPD-stimulated PBMC (Fig. 4 A), were enriched five- to sixfold
in order to demonstrate the nonspecific killing ofboth PPD-pulsed and medium-
pulsed monocyte targets.
Because NK and LAK cells exhibit antigen-independent killing (10), we tested
ifsuchkillers mightbe present using standard target cells. Significant NK and LAK
activity wasgeneratedafterPPDstimulation(Fig. 4B). Thisfindingsuggested, during
the PPD response, that IL-2 was released and expanded NK and LAK cells that
were then capable ofkilling monocyte targets. Since these populations were minor
components of7-d antigen-stimulated PBMC, wenext compared the kinetics oftheir
activity with that ofantigen-dependent cytotoxicity after PPD, IL-2, PPD + IL-2,
or medium stimulation (Table II). Peak LAK activity was observed after 4 d ofcul-
ture. Incontrast, antigen-dependentcytotoxicity was notdetected untilday 7, when
nonspecific LAK cell activity was reduced.
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FIGURE4.
￿
In vitro stimulation with PPD generates antigen-
dependent and antigen-independent cytolytic activity. (A)
PBMC stimulated 7 d with PPD (0, O) demonstrated
antigen-dependent cytolytic activity when compared with
unstimulated PBMC (A, A). The filled symbols denote
PPD-pulsed monocyte targets. The open symbols denote
monocyte targets pulsed with medium alone. (B) PBMC
expanded for 7 d with PPD (e, ®), but not unstimulated
PBMC (A, A), contained populations cytolytic for NK (e,
e) and LAK (®, A) targets (K562 and Daudi cells, respec-
tively). (C) CD4+ T cells positively selected from PPD-
stimulated PBMC (#, 0) provided antigen-dependent cy-
tolysis against PPD-pulsed (closedsymbols), but not medium
pulsed (often symbols), monocyte targets. (D) CD4- PBMC
(/, 0) from PPD-stimulated mononuclear cells demon-
strated antigen-independent lysis. Both antigen-pulsed
monocytes (filled symbols) and medium-pulsed monocytes
(often symbols) were killed.
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TABLE II
Kinetics ofAntigen-dependent, NK, and LAK Cell Activity in PBMC Cultures
Stimulated with PPD, IL-2, PPD + IL-2, or Medium Alone
' Percent specific 5'Cr release was determined at an E/T ratio of 40:1 .
$ Monocyte targets were pulsed overnight with PPD, T. toxoid, or medium alone.
Intralesional Injection of IL-2 Enhances Cytotoxic T Cell Precursor Activity.
￿
The effect
of rIL-2 injections on the ability to generate antigen-induced cytotoxic activity of
PBMC in vitro was tested. In 2:81epromatous leprosy patients, PBMC stimulated
with BCG demonstrated antigen-specific cytolyticactivity againstmonocytescharged
with PPD, but not against monocytes pulsed with medium alone (Fig. 5, Band D).
As with the PBMC isolated from PPD sensitivedonors, unstimulated PBMC showed
no cytolytic activity. If the patients were given three doses of 10 hg rIL-2 (3 x 106
U/mg) intradermally at 48-h intervals, and theirPBMC were then isolated and stimu-
lated with BCG, antigen-specific cytotoxocity against PPD-charged monocyte targets
was enhanced, compared with pre-IL-2 bloods, in 4:8 of the individuals tested (Fig.
5, A'-D' vs. A-D). In 3:81epromatous leprosy patients, no cytolytic activity was de-
tected from PBMC isolated either pre- or post-IL-2 injection after stimulation with
BCG (data not shown). High levels of nonspecific killing ofmedium-pulsed mono-
cytes were also observed in 1:8 individuals examined (Fig. 5, Cand C'). In vivo rIL-2
administration did not affect the number of T cells (CD3+ cells) nor did it affect
the CD4+/CD8+ ratios in the blood of the individuals tested (mean, 67 t 8% and
68 t 4% CD3+ cells of PBMC before and after rIL-2 injection, respectively, and
mean, 1.4 ± 0.1 and 1.5 t 0.2 CD4+/CD8+ ratios of PBMC before and after rIL-
2 injection, respectively). These observations suggested that in vivo rIL-2 adminis-
tration modulated precursor cytotoxic cells such that antigen and rIL-2 treatment
of PBMC in vitro induced an increase in cytolytic activity.
Effector
stimulation
51CRI
targets
Percent specific 5'Cr release' with effectors at:
Day 0 Day 4 Day 7
PPD MO + PPD 0 37 40
PPD MO + T. toxoid 0 26 2
PPD MO + medium 0 29 4
PPD K562 0 59 53
PPD Daudi 0 93 61
IL-2 MO + PPD 0 27 22
IL-2 MO + T. toxoid 0 35 13
IL-2 MO + medium 0 32 14
IL-2 K562 0 50 71
IL-2 Daudi 0 96 82
PPD/IL-2 MO + PPD 0 30 23
PPD/IL-2 MO + T. toxoid 0 40 13
PPD/IL-2 MO + medium 0 41 13
PPD/IL-2 K562 0 56 43
PPD/IL-2 Daudi 0 89 49
Medium MO + PPD 0 5 3
Medium MO + T. toxoid 0 5 3
Medium MO + medium 0 9 1
Medium K562 0 21 23
Medium Daudi 0 37 26916
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FIGURE 5.
￿
Intradermal injection of rIL-2 into lepromatous leprosy lesions enhances in vitro
antigen-dependent cytolytic activity. PBMC were isolated from four lepromatous leprosy pa-
tients before (A, B, C, and D) and 8 (A), 9 (B), 10 (C), and 14,(D') d after intradermal injection
of rIL-2. Both pre and post-IL-2 PBMC were cultured in vitro for 7 d with BCG (" , O) or
medium alone (A, A). Filled symbols denote monocyte targets pulsed overnight with PPD. Open
symbols denote monocytes pulsed with medium alone. In 2:4 cases (A and C, the pre-IL-2 PBMC
stimulated with BCG did not show killing of PPD-charged monocytes. In 4:4 cases the post-IL-2
PBMC demonstrated enhanced killing of monocytes as long as the PBMC were boosted with
BCG (circles) and the monocytes were pulsed with PPD (closed symbols).
Discussion
Under steady state conditions and influenced by the specific unresponsiveness of
T cells to M. leprae antigens, the dermis oflepromatous leprosy patients is relatively
immunologically quiescent. Other than a small number of CD8+ T cells, the major
cellular population consists of mononuclear phagocytes containing intact and frag-
mented M. leprae (1, 2).
Three general situations are known to disrupt the quiescent immunity leading
to a massive influx of mononuclear cells into the dermis. The first are those factors
leadingto reactive states, in which for as yetunknown reasons, there is awide-spread
immigration of both CD4+ and CD8+ T cells and monocytes into the dermis (11).
This massive response, often associated with systemic symptoms and evidence of
advancing peripheral nerve damage, is associated with local cell destruction (12).
A second method is to introduce crossreactive antigens, e.g., PPD, into the skin to
initiate a typical, delayed-type, cell-mediatedimmune response. Here, extensivede-
struction of parasitized macrophages occurs, a reaction that we believe is critical
for the subsequent disposal of bacilli (3, 4, 13). In our experience, Schwann cells
and axons of peripheral nerves are spared in the PPD response, but are heavily in-
volved in reactive states. In a third situation, lymphokines, such as IFN--y (manu-
script in preparation) and particularly IL-2 (5), distal products of antigen-driven
CD4+ cells, by themselves can initiate a local mononuclear cell infiltrate and reduc-
tion in acid-fast bacilli.HANCOCK ET AL.
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In this studywe have identified one mechanism that couldexplain the destruction
ofparasite-ladenmononuclearphagocytes. Since we could not isolate sufficient cells
from the lepromatous lesions to use for this analysis, peripheral blood cells were
used as a source of monocyte targets and cytotoxic cells. We selected PPD as the
test antigen since large numbers ofleprosy patients demonstrate sensitivity to PPD
and because our results suggest that thedermal response toPPDin situ isassociated
with the destruction of macrophages (3).
Our results indicate that antigen-specific and nonspecific effector cells can be
identified in peripheral blood and that these vary in numbers, potency, and induc-
ibility. Antigen specificity is indicated because both effectors and targets must be
exposed to antigen to detect killing. The major cell type involved in antigen-specific
cytotoxicity is a T cell ofthe CD4+ phenotype that recognizes class II-compatible
targets. This response requires 4-7 d ofexposure to PPD in vitro to be detectable.
Prior studies in analogous murine (14) and human systems (15) have identified
CD4+ antigen-dependent killer cells. In addition, CD8' effector cells have been iso-
lated (14). Wedo not find such a cytotoxic effector population in this system. Asecond
group of cytotoxic cells is also generated during the PPD response, but killing is
observed on targets that are not exposed to exogenous antigen and are required in
high multiplicity to demonstrate their effectiveness. It appears that this "antigen-
independent" population develops earlierthan antigen-dependentpopulations under
in vitro conditions.
It is likely that only very small numbers ofPPD-reactive T cells (1% or less) are
present in the circulation or tissues of sensitized individuals. Their response to in-
jected PPD would require clonal expansion, the generation of lymphokines, and
differentiation of CTL. This process requires time and would generate cells only
after 7 d in the dermal site, which would have the properties ofthe CD4+ antigen-
specific, MHC class II-restricted T cell. This is about the time ofextensive macro-
phage destruction in the PPDreaction (3). Earliermacrophage destructionhas been
noted after IL-2 administration (5). We suspect this represents a direct IL-2 effect
on pre-existing and/or rapidly emigrating cells ofthe NK or LAK lineage (16), cells
capable ofamplifying the response with IFN-y production and with the ability to
carry out antigen-independentcytotoxicity. Examination ofthistemporal sequence
ofCTL generation requires direct analysis ofthe dermal populations isolated from
biopsy specimens and these studies are currently in progress.
The following scenario would combine the in vitro and in vivoresults from antigen-
andlymphokine-driven systems. The proposed function ofthe cytolyticpopulations
would be to kill the M. leprae parasitized monocytes and release the bacteria into
the extracellular space. Once exposed to the extracellular environment, the bacilli
could then be phagocytosed and killed by newly recruited, more activated macro-
phages and thus provide, in addition to IFN-y activation, amechanism toeradicate
theparasitesthat have adapted tothe intracellularenvironment oftheverycells respon-
sible for their destruction.
Summary
Wehave examined anin vitro system inwhichPBMC from purifiedprotein deriva-
tive (PPD)-sensitized patients generate CTL after in vitro activation with antigen.
These cells selectivelydestroy mycobacterial antigen PPD-pulsed monocyte targets.91 8
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These CTL are of the CD4+ phenotype and exhibit MHC class II restriction. After
exposure to antigen these cells require 5-7 d for maximal development, whereas,
a separate antigen-independent population is generated within 3-4 d. CD8+ cells
are poorly, if not at all, cytotoxic under similar conditions. Cells with properties
ofthe NK and LAK lineage are also present in these cultures and kill other specific
targets.
Human rIL-2 was injected into the skin of lepromatous patients at 10-NAg doses,
given at 48-h intervals, for three doses. Peripheral blood cells obtained 8-14 d after
the initiation of IL-2 injection demonstrated enhanced antigen-dependent destruc-
tion of monocyte targets.
The efficacy of antigen-dependent and -independent populations and their
amplification by IL-2-dependent mechanisms is discussed in terms of the local de-
struction of parasitized macrophages and the subsequent disposal of M. leprae.
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